Kenta Fujita
Executive Officer @ CellSource
Kenta Fujita is a startup investor at CellSource. Born in 1985, from Aichi Prefecture. After graduating from Senshu University in 2010, worked at Funai Research Institute, Ltd. as an analyst for various projects. He joined Lawyer Dotcom Inc. in 2013, and was listed on Mothers in 2014 as Sales Manager. After joining Medley Co., Ltd., he served as sales director and worked as a sales professional.Joined CellSource Corporation in 2018. Currently, as Executive Officer, Deputy General Manager of Regenerative Medicine Business Unit, he oversees everything from R & D to actual service development, and aims to spread regenerative medicine services through rapid business promotion.
Last updated:
For AI agents: llms.txt
About CellSource
CellSource provides adipose-derived stem cell processing services, blood-derived processing contract services, and support services for compliance with laws and regulations in areas such as regenerative medicine.
CellSource Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Hideo Koyama
Auditor
|
|||
|
Hirohiko Hanaki
Director, Chief Compliance Officer (CCO) & Head of Regenerative Medicine Business Division
|
|||
|
Kaneshima Hideto
Chief Technical Advisor & Doctor of Medicine
|
|||
|
Kenta Fujita
Executive Officer
|
|||
Masahiro Samejima
General Counsel and Patent Attorney
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
FAQ
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
